C 39 (C39)

synthetic glycolipid which induced complete regression of transplants of a syngeneic murine fibrosarcoma

Also Known As:

C39; C-39; methyl 6-O-(2-tetradecyl-3-hydroxyoctadecanoyl)-alpha-D-glucopyranoside; alpha-D-Glucopyranoside, methyl, 6-(3-hydroxy-2-tetradecyloctadecanoate)

Networked: 42 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Arrojo, Roberto: 1 article (10/2020)
2.	Cardillo, Thomas M: 1 article (10/2020)
3.	Chang, Chien-Hsing: 1 article (10/2020)
4.	Goldenberg, David M: 1 article (10/2020)
5.	Liu, Donglin: 1 article (10/2020)
6.	Rossi, Diane L: 1 article (10/2020)
7.	Sharkey, Robert M: 1 article (10/2020)
8.	Zalath, Maria B: 1 article (10/2020)
9.	Adams, Rachel Sayko: 1 article (01/2020)
10.	Larson, Mary Jo: 1 article (01/2020)

Related Diseases

1.	Infarction (Infarctions) 04/01/2007 - "The cardioprotective effect was lost when the effluent was left at room temperature during 24 h (infarct size, 40 +/- 3%) or heated to 70 degrees C (26 +/- 4%, P < 0.05) or 100 degrees C (39 +/- 1%, P < 0.001). " 01/01/1977 - "Conscious dogs, pretreated orally with perhexiline 200 mg/day/7 days or 400 mg/day/7 days and monitored without anesthesia or analgesia for 72 hours after coronary ligation had smaller infarcts (P200=26+/-5; P400=26+/-4; C=39+/-5 g; P less than .05) lower plasma peak creatine phosphokinase activity (P less than .05) and reduced heart rate (P400=198+/-8; C=226+/-8 beats/min; P less than .05) and reduced incidence of ventricular ectopic beats (P less than .05). "
2.	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/01/1977 - "Conscious dogs, pretreated orally with perhexiline 200 mg/day/7 days or 400 mg/day/7 days and monitored without anesthesia or analgesia for 72 hours after coronary ligation had smaller infarcts (P200=26+/-5; P400=26+/-4; C=39+/-5 g; P less than .05) lower plasma peak creatine phosphokinase activity (P less than .05) and reduced heart rate (P400=198+/-8; C=226+/-8 beats/min; P less than .05) and reduced incidence of ventricular ectopic beats (P less than .05). "
3.	Hepatitis B 01/01/2014 - "The study group consisted of 1206 liver biopsy specimens, etiologically diagnosed as hepatitis C - 1021 (84.66%) cases, hepatitis B - 100 (8.29%) cases, hepatitis B and C - 39 (3.23%) cases, hepatitis B and D - 39 (3.23%) cases, hepatitis C and toxicity - six (0.49%) cases, hepatitis B, C and D - one case (0.08%). " 04/01/2006 - "The patients who were IgM anti-HAV negative included hepatitis B (321 patients), C (39 patients), E (507 patients) and unclassified (844 patients). "
4.	Lower Urinary Tract Symptoms 01/01/2003 - "The study is based on prospective analysis of 103 patients: (a) 33 patients (group A) presented lower urinary tract symptoms secondary to BPH with normal serum PSA values, DRE and TRUS negative for suspected PCa; (b) 31 patients (group B) with histologically diagnosed PCa; (c) 39 patients (group C) with borderline serum PSA values, DRE and TRUS normal, two ultrasound (US)-guided random prostate biopsies negative for PCa. "
5.	Hepatitis C 01/01/2014 - "The study group consisted of 1206 liver biopsy specimens, etiologically diagnosed as hepatitis C - 1021 (84.66%) cases, hepatitis B - 100 (8.29%) cases, hepatitis B and C - 39 (3.23%) cases, hepatitis B and D - 39 (3.23%) cases, hepatitis C and toxicity - six (0.49%) cases, hepatitis B, C and D - one case (0.08%). "

Related Drugs and Biologics

1.	Perhexiline
2.	Creatine Kinase (Creatine Phosphokinase)
3.	Glycolipids
4.	Emulsions
5.	C 76 (C76)
6.	B 31
7.	Hepatitis A Antibodies
8.	Thrombospondins
9.	Carboplatin (JM8)
10.	von Willebrand Factor

Related Therapies and Procedures

1.	Ligation
2.	Anesthesia
3.	Analgesia
4.	Intralesional Injections
5.	X-Ray Film